You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Antagonists

Showing 1 - 25 of 1,601
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

Recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • 6-month course of antiandrogen drugs
  • Long-term course of antiandrogen drugs
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)

Recruiting
  • Prostatic Neoplasms
  • Cheongju, Korea, Republic of
  • +9 more
Jul 28, 2021

Transgender Women Trial in Pathum Wan (Estradiol, Estradiol and Anti-Androgen, No intervention)

Completed
  • Transgender Women
  • Estradiol
  • +2 more
  • Pathum Wan, Bangkok, Thailand
    Faculty of Sports Science, Chulalongkorn University
Nov 2, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)

Recruiting
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Antiandrogen Therapy
  • +5 more
  • Duarte, California
  • +15 more
Jan 24, 2023

In-vitro Diagnostic Test to Predict COVID-19 Mortality and

Recruiting
  • SARS-CoV 2
  • +5 more
  • CAG length <22
  • CAG length >=22
  • Madrid, Spain
    Hospital Universitario Ramon y Cajal
Feb 17, 2022

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

Prostate Cancer Trial in Worldwide (Degarelix, approved GnRH agonist, Radiotherapy)

Recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +38 more
Sep 3, 2021

Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Québec, Canada
    CHU de Québec-Université Laval
Jul 13, 2022

Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

Recruiting
  • Prostatic Hyperplasia
  • Prostate Cancer
  • Turku, Finland
  • +1 more
Aug 17, 2023

Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasms
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Macquarie University, New South Wales, Australia
  • +131 more
Jan 5, 2023

Prostate Cancer Trial (Darolutamide 300 mg, Placebo of Darolutamide)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Placebo of Darolutamide
  • (no location specified)
Feb 10, 2022

Polycystic Ovary Syndrome Trial (Ganirelix)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • (no location specified)
Feb 20, 2023

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)

Active, not recruiting
  • Prostatic Neoplasms
  • Copenhagen, Denmark
  • +4 more
Aug 12, 2021